The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Anogenital Distance or Digit Length Ratio as Measures of Fetal Androgen Exposure: Relationship to Male Reproductive Development and Its Disorders
Abstract
CONTEXT: Male reproductive disorders evident at birth or in young adulthood are remarkably common. They are hypothesized to comprise a testicular dysgenesis syndrome (TDS), with a fetal origin involving mild androgen deficiency. EVIDENCE ACQUISITION: Testing this hypothesis requires "seeing back in time." Two ways have been proposed: measurement of anogenital distance (AGD), or measurement of the 2:4 digit length ratio. This review assesses the evidence that they reflect fetal androgen exposure and might be used to provide insight into the origin of TDS disorders. EVIDENCE SYNTHESIS: Supporting evidence for AGD derives from rat experimental studies that identified a fetal masculinization programming window, within which androgen action determines adult reproductive organ size, TDS disorders, and AGD. In humans, AGD is positively correlated to testis size, sperm count/fertility, penis length, and T levels, consistent with rat experimental data. The 2:4 digit ratio also shows associations with these parameters, but inconsistently between studies; evidence that the 2:4 digit ratio accurately reflects fetal androgen exposure is also equivocal. CONCLUSIONS: AGD appears to provide a reliable guide to fetal androgen exposure, although available data are limited. The next steps are to: standardize AGD measurement; obtain age-specific population data; and use AGD to evaluate the importance of fetal androgens in determining reproductive disorders and variation in testis/penis size and sperm count in the normal population. These studies should identify what, if any, clinical applications of AGD measurement are feasible--for example, its ability to predict adult-onset reproductive function and disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skakkebæk, N. E., Rajpert-De Meyts, E., & Main, K. M. (2001) · Human Reproduction · doi:10.1093/humrep/16.5.972 · Cited by 2,260
Decrease in anogenital distance among male infants with prenatal phthalate exposure
Swan, S. H., Main, K. M., Liu, F., Stewart, S. L., Kruse, R. L., Calafat, A. M., Mao, C. S., Redmon, J. B., Ternand, C. L., Sullivan, S., et al. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8100 · Cited by 1,586
Manning, J. T., Scutt, D., Wilson, J., & Lewis-Jones, D. I. (1998) · Human Reproduction · doi:10.1093/humrep/13.11.3000 · Cited by 1,467
Fetal nutrition and adult disease
Godfrey, K. M., & Barker, D. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1344s · Cited by 1,339
Sharpe, R. M., McKinnell, C., Kivlin, C., & Fisher, J. S. (2003) · Reproduction · doi:10.1530/rep.0.1250769 · Cited by 1,272
Self-citation2nd to 4th digit ratios, fetal testosterone and estradiol
Lutchmaya, S., Baron-Cohen, S., Raggatt, P., Knickmeyer, R., & Manning, J. T. (2004) · Early Human Development · doi:10.1016/j.earlhumdev.2003.12.002 · Cited by 919
Welsh, M., Saunders, P. T. K., Fisken, M., Scott, H. M., Hutchison, G. R., Smith, L. B., & Sharpe, R. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34241 · Cited by 781 · cited 6×
“Only early (MPW) androgen exposure virilized AGD in exposed females, as expected (11), and this treatment (but not late gestation androgen exposure) also increased length of digit 2, making it more male-like whereas it failed to have a ‘male-like’ effect on digit 4.”
InfluentialSeckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Yeh, S., Tsai, M.-Y., Xu, Q., Mu, X.-M., Lardy, H., Huang, K.-E., Lin, H., Yeh, S.-D., Altuwaijri, S., Zhou, X., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212474399 · Cited by 668
Developmental basis of sexually dimorphic digit ratios
Zheng, Z., & Cohn, M. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108312108 · Cited by 661
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
Lee, P. A., Nordenström, A., Houk, C. P., Ahmed, S. F., Auchus, R., Baratz, A., Baratz Dalke, K., Liao, L.-M., Lin-Su, K., Looijenga 3rd, L. H. J., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000442975 · Cited by 1,273
Radke, E. G., Braun, J. M., Meeker, J. D., & Cooper, G. S. (2018) · Environment International · doi:10.1016/j.envint.2018.07.029 · Cited by 439
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Anogenital distance as a marker of androgen exposure in humans
Thankamony, A., Pasterski, V., Ong, K. K., Acerini, C. L., & Hughes, I. A. (2016) · Andrology · doi:10.1111/andr.12156 · Cited by 238
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
Prenatal phthalate exposure and reproductive function in young men
Axelsson, J., Rylander, L., Rignell-Hydbom, A., Lindh, C. H., Jönsson, B. A. G., & Giwercman, A. (2015) · Environmental Research · doi:10.1016/j.envres.2015.02.024 · Cited by 107
Mendiola, J., Sánchez-Ferrer, M. L., Jiménez-Velázquez, R., Cánovas-López, L., Hernández-Peñalver, A. I., Corbalán-Biyang, S., Carmona-Barnosi, A., Prieto-Sánchez, M. T., Nieto, A., & Torres-Cantero, A. M. (2016) · Human Reproduction · doi:10.1093/humrep/dew163 · Cited by 80
“In observational studies, AGD is a biomarker of prenatal exposure to endocrine disruptors (Swan et al., 2005, 2015; Bornehag et al., 2015) and androgens during the formation of the reproductive system (Dean and Sharpe, 2013; Jain and Singal, 2013).”
BackgroundOntogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67
Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66
Barrett, E. S., Sathyanarayana, S., Mbowe, O., Thurston, S. W., Redmon, J. B., Nguyen, R. H. N., & Swan, S. H. (2017) · Environmental Health Perspectives · doi:10.1289/ehp875 · Cited by 65
Le Moal, J., Sharpe, R. M., Jϕrgensen, N., Levine, H., Jurewicz, J., Mendiola, J., Swan, S. H., Virtanen, H., Christin-Maître, S., Cordier, S., et al. (2016) · The European Journal of Public Health · doi:10.1093/eurpub/ckv153 · Cited by 48
Self-citationPan, Z., Zhu, F., & Zhou, K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.696879 · Cited by 34
Fabregues, F., González-Foruria, I., Peñarrubia, J., & Carmona, F. (2018) · Human Reproduction · doi:10.1093/humrep/dey244 · Cited by 34
“In observational studies, AGD has been demonstrated as a biomarker of prenatal exposure to endocrine disruptors (Swan et al., 2005; Bornehag et al., 2015) and androgens during the development of the reproductive system (Dean and Sharpe, 2013; Jain and Singal, 2013).”
BackgroundCrestani, A., Arfi, A., Ploteau, S., Breban, M., Boudy, A.-S., Bendifallah, S., Ferrier, C., & Darai, E. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa023 · Cited by 28
Peters, H. E., Laeven, C. H. C., Trimbos, C. J. M. A., van de Ven, P. M., Verhoeven, M. O., Schats, R., Mijatovic, V., & Lambalk, C. B. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.06.029 · Cited by 24
Anogenital Distance: A Marker of Steroidal Endocrine Disruption
Swan, S. H., & Kristensen, D. M. (2018) · Encyclopedia of Reproduction · doi:10.1016/b978-0-12-801238-3.64379-9 · Cited by 17
A short anogenital distance on MRI is a marker of endometriosis
Crestani, A., Abdel Wahab, C., Arfi, A., Ploteau, S., Kolanska, K., Breban, M., Bendifallah, S., Ferrier, C., & Darai, E. (2021) · Human Reproduction Open · doi:10.1093/hropen/hoab003 · Cited by 15
Androgens, Endometriosis and Pain
Evans, S. F., Hull, M. L., Hutchinson, M. R., & Rolan, P. E. (2021) · Frontiers in Reproductive Health · doi:10.3389/frph.2021.792920 · Cited by 14
Anogenital Distance and Endometriosis: Results of a Case–Control Study
Buggio, L., Somigliana, E., Sergenti, G., Ottolini, F., Dridi, D., & Vercellini, P. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01009-7 · Cited by 8
Dural, O., Kurbanova, T., Yasa, C., Ugurlucan, F. G., Selvi, E., Ozdemir, P. K., & Akhan, S. E. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.01.017 · Cited by 8
Metadata
- Authors
- Dean, A., & Sharpe, R. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-06-01
- Volume
- 98
- Issue
- 6
- Pages
- 2230-2238
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008951729
- Cited by
- 286
- References
- 76
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.